Top-News

Nuvo Pharmaceuticals News

Keine aktuellen Kursdaten verfügbar
WKN: A2AD5S
ISIN: CA67092F1045
US-Symbol: MRVFF
Typ: Aktie

Nuvo Pharmaceuticals News

29.07.21 - PR Newswire
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea PR Newswire
12.04.21 - ACCESSWIRE
Miravo Healthcare(TM) to Present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22, 2021 at 10:00 a.m. EST
MISSISSAUGA, ON / ACCESSWIRE / April 12, 2021 / Nuvo Pharmaceuticals ® Inc. (TSX:MRV)(OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused ...
21.12.20 - PR Newswire
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire
18.12.20 - PR Newswire
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ PR Newswire
16.11.20 - PR Newswire
Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results
Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results PR Newswire
02.11.20 - PR Newswire
Nuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details
Nuvo Pharmaceuticals™ Announces Third Quarter 2020 Results Release Date and Conference Call Details PR Newswire
12.10.20 - PR Newswire
Growth Company Investor Presentations Now Available for On-Demand Viewing
Growth Company Investor Presentations Now Available for On-Demand Viewing Individual and institutional investors as well as advisors are invited to log-on to ...
05.10.20 - PR Newswire
Live Growth Opportunities Investor Conference October 8th
Live Growth Opportunities Investor Conference October 8th Company executives will share vision and answer audience questions at VirtualInvestorConferences.com PR Newswire
05.10.20 - PR Newswire
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th - Company invites individual and institutional investors, as well as advisors and analysts, to ...
05.10.20 - PR Newswire
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th
Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th PR Newswire
14.09.20 - PR Newswire
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th PR Newswire
09.09.20 - PR Newswire
Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx™ - For The Acute Treatment of Migraine
Nuvo Pharmaceuticals® Announces The Canadian Commercial Launch of Suvexx™ - For The Acute Treatment of Migraine PR Newswire
10.08.20 - PR Newswire
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results PR Newswire
27.07.20 - PR Newswire
Nuvo Pharmaceuticals™ Announces Second Quarter 2020 Results Release Date and Conference Call Details
Nuvo Pharmaceuticals™ Announces Second Quarter 2020 Results Release Date and Conference Call Details PR Newswire
12.05.20 - PR Newswire
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders
Nuvo Pharmaceuticals® Announces Director Election Results of its Annual & Special Meeting of Shareholders PR Newswire
11.05.20 - PR Newswire
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results PR Newswire
30.04.20 - PR Newswire
C-Suite At The Open: Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc., tells his Company's Story. Filmed on April 24, 2020
C-Suite At The Open: Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc., tells his Company's Story. Filmed on April 24, 2020 Canada NewsWire
27.04.20 - PR Newswire
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results Release Date and Virtual Annual & Special Meeting of Shareholders PR Newswire
31.03.20 - PR Newswire
Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020
Nuvo Pharmaceuticals® Announces Approval of Takeda's Cabpirin Tablets in Japan, Triggering a US$2.0 Million Milestone Payment due in Q2 2020 PR Newswire
04.03.20 - PR Newswire
Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States
Nuvo Pharmaceuticals® Announces "at risk" Launch of Generic Version of Vimovo in the United States PR Newswire

Newssuche

Videos

newspaper
24.04.24
Technical Trading: AUD/USD mit Mega Chance
AUD/USD Long Typ: Turbo Open End WKN: UM0EHU Hebel: 6,42 Laufzeit: OpenEnd Einstieg: Market ... Mehr »